|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Best Practice
Open Access
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Form
Ethics Disclosure form
All issues
Ahead-of Print Articles
Most Read Articles
Most Cited Articles
Radiation Oncology Journal
Search
Author Index
Radiation Oncology Journal
Search
> Browse Articles > Search
P
e
r
i
p
h
e
r
a
l
b
l
o
o
d
l
y
m
p
h
o
c
y
t
e
c
h
a
n
g
e
s
a
f
t
e
r
s
t
e
r
e
o
t
a
c
t
i
c
a
b
l
a
t
i
v
e
b
o
d
y
r
a
d
i
o
t
h
e
r
a
p
y
t
o
l
u
n
g
o
r
l
i
v
e
r
m
e
t
a
s
t
a
s
e
s
i
n
p
a
t
i
e
n
t
s
w
i
t
h
o
l
i
g
o
m
e
t
a
s
t
a
t
i
c
c
a
n
c
e
r
s
S
e
r
g
e
y
N
i
k
o
l
a
e
v
i
c
h
N
o
v
i
k
o
v
,
I
r
i
n
a
A
l
e
k
s
a
n
d
r
o
v
n
a
B
a
l
d
u
e
v
a
,
A
n
t
o
n
Y
u
r
i
e
v
i
c
h
Z
o
z
u
l
y
a
,
N
a
t
a
l
y
a
V
i
k
t
o
r
o
v
n
a
E
m
e
l
y
a
n
o
v
a
,
D
m
i
t
r
i
y
V
i
k
t
o
r
o
v
i
c
h
G
i
r
d
y
u
k
,
A
n
d
r
e
y
I
v
a
n
o
v
i
c
h
A
r
s
e
n
y
e
v
,
E
l
e
n
a
A
l
e
x
a
n
d
r
o
v
n
a
,
E
l
e
n
a
I
v
a
n
o
v
n
a
T
y
u
r
y
a
e
v
a
,
E
.
I
.
F
i
l
i
p
E
v
g
e
n
e
v
i
c
h
A
n
t
i
p
o
v
,
M
i
k
h
a
i
l
M
a
r
k
o
v
i
c
h
G
i
r
s
h
o
v
i
c
h
,
S
e
r
g
e
y
V
a
s
i
l
e
v
i
c
h
K
a
n
a
y
e
v
Radiat Oncol J.
2023;41(1):23-31. Published online 2023 Feb 27 DOI:
https://doi.org/10.3857/roj.2022.00521
A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev
Radiat Oncol J.
2022;40(3):200-207. Published online 2022 Sep 30 DOI:
https://doi.org/10.3857/roj.2022.00339
Cited By 1
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
Radiat Oncol J.
2022;40(3):192-199. Published online 2022 Sep 27 DOI:
https://doi.org/10.3857/roj.2022.00101
Cited By 1
Clinical Investigations
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J.
2022;40(2):111-119. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.01060
Cited By 4
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J.
2022;40(1):20-28. Published online 2022 Mar 25 DOI:
https://doi.org/10.3857/roj.2021.00934
Cited By 3
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J.
2021;39(4):304-314. Published online 2021 Dec 17 DOI:
https://doi.org/10.3857/roj.2021.00815
Cited By 6
Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
Ben Man Fei Cheung, Kin Sang Lau, Victor Ho Fun Lee, To Wai Leung, Feng-Ming Spring Kong, Mai Yee Luk, Kwok Keung Yuen
Radiat Oncol J.
2021;39(4):254-264. Published online 2021 Oct 26 DOI:
https://doi.org/10.3857/roj.2021.00311
Cited By 2
Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
Jason Liu, Colton Ladbury, Arya Amini, Scott Glaser, Jonathan Kessler, Aram Lee, Yi-Jen Chen
Radiat Oncol J.
2021;39(2):113-121. Published online 2021 Jun 18 DOI:
https://doi.org/10.3857/roj.2021.00213
Cited By 1
Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy
Debnarayan Dutta, Kaushik Jagannath Kataki, Shibu George, Sruthi K. Reddy, Ajay Sashidharan, Rajesh Kannan, Ram Madhavan, Haridas Nair, Tushar Tatineni, Raghavendra Holla
Radiat Oncol J.
2020;38(4):253-261. Published online 2020 Nov 30 DOI:
https://doi.org/10.3857/roj.2020.00472
Cited By 2
Clinical Investigationses
Maximum standardized uptake value at pre-treatment PET in estimating lung cancer progression after stereotactic body radiotherapy
Jisun Park, Yunseon Choi, Ki Jung Ahn, Sung Kwang Park, Heunglae Cho, Ji Young Lee
Radiat Oncol J.
2019;37(1):30-36. Published online 2019 Mar 31 DOI:
https://doi.org/10.3857/roj.2019.00010
Cited By 8
Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
Kyung Hwa Lee, Jeong Il Yu, Hee Chul Park, Su Yeon Park, Jung Suk Shin, Eun Hyuk Shin, Sungkoo Cho, Sang Hoon Jung, Young Yih Han, Do Hoon Lim
Radiat Oncol J.
2018;36(2):129-138. Published online 2018 Jun 29 DOI:
https://doi.org/10.3857/roj.2017.00598
Cited By 15
Clinical Investigations
Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
Hun Jung Kim, Jeong Hoon Phak, Woo Chul Kim
Radiat Oncol J.
2016;34(4):260-264. Published online 2016 Jun 17 DOI:
https://doi.org/10.3857/roj.2015.01571
Cited By 8
Physics Contribution
A
f
e
a
s
i
b
i
l
i
t
y
s
t
u
d
y
e
v
a
l
u
a
t
i
n
g
t
h
e
r
e
l
a
t
i
o
n
s
h
i
p
b
e
t
w
e
e
n
d
o
s
e
a
n
d
f
o
c
a
l
l
i
v
e
r
r
e
a
c
t
i
o
n
i
n
s
t
e
r
e
o
t
a
c
t
i
c
a
b
l
a
t
i
v
e
r
a
d
i
o
t
h
e
r
a
p
y
f
o
r
l
i
v
e
r
c
a
n
c
e
r
b
a
s
e
d
o
n
i
n
t
e
n
s
i
t
y
c
h
a
n
g
e
o
f
G
d
-
E
O
B
-
D
T
P
A
-
e
n
h
a
n
c
e
d
m
a
g
n
e
t
i
c
r
e
s
o
n
a
n
c
e
i
m
a
g
e
s
S
a
n
g
H
o
o
n
J
u
n
g
,
J
e
o
n
g
I
l
Y
u
,
H
e
e
C
h
u
l
P
a
r
k
,
D
o
H
o
o
n
L
i
m
,
Y
o
u
n
g
y
i
h
H
a
n
Radiat Oncol J.
2016;34(1):64-75. Published online 2016 Mar 30 DOI:
https://doi.org/10.3857/roj.2016.34.1.64
Cited By 13
A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique
Antonio Pontoriero, Giuseppe Iatì, Stefano Pergolizzi
Radiat Oncol J.
2015;33(3):261-264. Published online 2015 Sep 30 DOI:
https://doi.org/10.3857/roj.2015.33.3.261
Cited By 4
Clinical Investigations
Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
Eonju Lee, Tae Gyu Kim, Hee Chul Park, Jeong Il Yu, Do Hoon Lim, Heerim Nam, Hyebin Lee, Joon Hyeok Lee
Radiat Oncol J.
2015;33(3):217-225. Published online 2015 Sep 30 DOI:
https://doi.org/10.3857/roj.2015.33.3.217
Cited By 20
Stereotactic radiotherapy for early stage non-small cell lung cancer
Umberto Ricardi, Serena Badellino, Andrea Riccardo Filippi
Radiat Oncol J.
2015;33(2):57-65. Published online 2015 Jun 30 DOI:
https://doi.org/10.3857/roj.2015.33.2.57
Cited By 29
Stereotactic body radiotherapy for solitary spine metastasis
Sunyoung Lee, Mison Chun, MiJo Lee
Radiat Oncol J.
2013;31(4):260-266. Published online 2013 Dec 31 DOI:
https://doi.org/10.3857/roj.2013.31.4.260
Cited By 6
Physics Contributions
Efficient approach for determining four-dimensional computed tomography-based internal target volume in stereotactic radiotherapy of lung cancer
Seung-Gu Yeo, Eun Seog Kim
Radiat Oncol J.
2013;31(4):247-251. Published online 2013 Dec 31 DOI:
https://doi.org/10.3857/roj.2013.31.4.247
Cited By 18
1
|
Journal Impact Factor 2.3